Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device Industry Amps Up Efforts To Repeal Device Tax In Lame Duck Session

This article was originally published in The Gray Sheet

Executive Summary

Industry groups flew in more than 50 CEOs to visit Capitol Hill, launched an ad campaign and released an impact report last week as part of a stepped-up effort to get Congress to repeal the impending medical device tax before it goes into effect Jan. 1.

You may also be interested in...



Industry Efforts Against Device Tax Haven't Slowed Down, Despite Suspension

The long-game effort by industry advocates to achieve permanent repeal of the device excise tax has switched from quantifying the detrimental impacts of the tax to spotlighting the positive outcomes from the recently enacted two-year suspension of the tax.

PhRMA CEO: Ubl Pick Brings User Fee, Reimbursement Expertise

Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill and executing well-regarded public relations campaign of the kind the drug industry might need as it enters political maelstrom on pricing.

PhRMA CEO: Ubl Pick Would Bring User Fee, Reimbursement Expertise

Steve Ubl has led AdvaMed for 10 years, raising profile of device industry on Capitol Hill, but also developing reputation of his own as a policy wonk.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT031739

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel